CLOV vs SHW · rev $1.37B vs P/E 29, rev $23.10B
Clover Health Investments Corp (CLOV) versus Sherwin-Williams Co (SHW) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Sherwin-Williams Co (SHW) is a specialty chemicals company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported SHW revenue for 2024-12-31 was $23.10B. Net income was $2.68B. Revenue was up 0.2% from 2023-12-31 to 2024-12-31. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
CLOV currently screens at market cap $1.55B. SHW currently screens at market cap $75.30B and trailing P/E 29.3.
Not investment advice. Open the CLOV and SHW stock pages for the full models.
Not investment advice.